Bio Identical Hormones Market
According to Intent Market Research, the Bio Identical Hormones Market is expected to grow from USD 1.7 billion in 2023 at a CAGR of 7.8% to touch USD 2.8 billion by 2030. The Bio Identical Hormones Market is dominated by key players such as, Bayer AG, Abbott Laboratories, Merck & Co., Inc., Allergan (AbbVie), and Mylan N.V.